(Q51764065)

English

DA-1229, a novel and potent DPP4 inhibitor, improves insulin resistance and delays the onset of diabetes.

scientific article published on 20 October 2011

In more languages
default values for all languages
No label defined

No description defined

Statements

DA-1229, a novel and potent DPP4 inhibitor, improves insulin resistance and delays the onset of diabetes. (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit